Akari Therapeutics Plc (AKTX)
6.15
+0.33
(+5.67%)
USD |
NASDAQ |
May 07, 14:15
Akari Therapeutics Free Cash Flow : -10.59M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| DBV Technologies SA | -122.10M |
| Cellectis SA | -43.68M |
| Biodexa Pharmaceuticals Plc | -8.310M |
| Mereo BioPharma Group Plc | -31.36M |
| Bicycle Therapeutics Plc | -231.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.039M |
| Cash from Financing (Quarterly) | 5.764M |
| Free Cash Flow to Equity (Quarterly) | -1.676M |
| Free Cash Flow to Firm (Quarterly) | -2.305M |
| Free Cash Flow Yield | -17.88% |